Price Alert

Augmedix Inc. (AUGX)

NASDAQ: AUGX · Real-Time Price · USD

2.35

0.00 (0.00%)

At close: Oct 01, 2024, 9:57 PM

Augmedix Statistics

Share Statistics

Augmedix has 49.43M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	49.43M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	67.45%
Shares Floating	24.99M
Failed to Deliver (FTD) Shares	1,416
FTD / Avg. Volume	0.18%

Short Selling Information

The latest short interest is 1.34M, so 0% of the outstanding shares have been sold short.

Short Interest	1.34M
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	19.62

Valuation Ratios

The PE ratio is -13.41 and the forward PE ratio is -6.7. Augmedix's PEG ratio is 0.35.

PE Ratio	-13.41
Forward PE	-6.7
PS Ratio	5.73
Forward PS	1.9
PB Ratio	11.02
P/FCF Ratio	-13.86
PEG Ratio	0.35

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Augmedix.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.41, with a Debt / Equity ratio of 1.11.

Current Ratio	2.41
Quick Ratio	2.41
Debt / Equity	1.11
Debt / EBITDA	-1.46
Debt / FCF	-1.39
Interest Coverage	-8.34

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$31.37K
Profits Per Employee	$-13.41K
Employee Count	1,430
Asset Turnover	0.67
Inventory Turnover	n/a

Taxes

Income Tax	145K
Effective Tax Rate	-0.76%

Stock Price Statistics

The stock price has increased by 3.52% in the last 52 weeks. The beta is -0.19, so Augmedix's price volatility has been lower than the market average.

Beta	-0.19
52-Week Price Change	3.52%
50-Day Moving Average	2.3
200-Day Moving Average	2.97
Relative Strength Index (RSI)	74.06
Average Volume (20 Days)	808,771

Income Statement

In the last 12 months, Augmedix had revenue of 44.85M and earned -19.17M in profits. Earnings per share was -0.44.

Revenue	44.85M
Gross Profit	21.53M
Operating Income	-18.78M
Net Income	-19.17M
EBITDA	-17.68M
EBIT	-16.77M
Earnings Per Share (EPS)	-0.44

Full Income Statement

Balance Sheet

The company has 46.34M in cash and 25.85M in debt, giving a net cash position of 20.5M.

Cash & Cash Equivalents	46.34M
Total Debt	25.85M
Net Cash	20.5M
Retained Earnings	-144.96M
Total Assets	53.67M
Working Capital	15.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.44M and capital expenditures -3.1M, giving a free cash flow of -18.55M.

Operating Cash Flow	-15.44M
Capital Expenditures	-3.1M
Free Cash Flow	-18.55M
FCF Per Share	-0.42

Full Cash Flow Statement

Margins

Gross margin is 47.99%, with operating and profit margins of -41.87% and -42.74%.

Gross Margin	47.99%
Operating Margin	-41.87%
Pretax Margin	-42.42%
Profit Margin	-42.74%
EBITDA Margin	-39.42%
EBIT Margin	-41.87%
FCF Margin	-41.35%

Dividends & Yields

AUGX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for AUGX.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-2.62
Piotroski F-Score	2